cytarabine has been researched along with Acrania in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Karp, JE; Smith, BD | 1 |
Asahara, S; Chinzei, T; Hasuike, N; Maeda, N; Maeda, Y; Okada, Y; Okutani, T; Saigo, K; Satake, S; Takata, M; Tamura, M; Tasaka, K; Tomofuji, Y | 1 |
Champlin, RE; Gajewski, JL; Gekelman, L; Hirji, KF; Ho, WG; Jacobs, AD; Nimer, SD | 1 |
3 other study(ies) available for cytarabine and Acrania
Article | Year |
---|---|
Developmental clinical trials: building one step at a time.
Topics: Antineoplastic Agents; Apoptosis; Clinical Trials, Phase I as Topic; Cytarabine; Drug Resistance, Neoplasm; Humans; Leukemia, Myeloid, Acute; Neural Tube Defects; Pyridines; Research Design; Thiosemicarbazones | 2006 |
[All-trans retinoic acid combined with low-dose cytosine arabinoside treatment for acute myelogenous leukemia with trilineage myelodysplasia--a case report].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Leukemia, Myeloid, Acute; Middle Aged; Neural Tube Defects; Tretinoin | 2001 |
Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome.
Topics: Age Factors; Anemia, Aplastic; Anemia, Refractory, with Excess of Blasts; Cytarabine; Daunorubicin; Humans; Leukemia, Myeloid, Acute; Multivariate Analysis; Neural Tube Defects; Preleukemia; Prognosis; Regression Analysis; Survival Rate; Thioguanine | 1989 |